Niraj K. Shenoy

Hematology | Oncology

675 N St Clair St Ste 20-150
Galter Pavilion
Chicago, IL 60611

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 41 publications

Hypoxia-inducible factors drive miRNA-mediated downregulation of L2HGDH and HIF1A in clear cell renal cancer independent of 14q deletion.

Hypoxia-inducible factors drive miRNA-mediated downregulation of L2HGDH and HIF1A in clear cell renal cancer independent of 14q deletion.

Journal: bioRxiv : the preprint server for biology

Published: November 24, 2025

Contemporary assessment of diagnostic performance and histologic concordance of renal mass biopsy with surgical pathology.

Contemporary assessment of diagnostic performance and histologic concordance of renal mass biopsy with surgical pathology.

Journal: BJUI compass

Published: September 11, 2025

In vivo anti-tumor activity of high-dose parenteral ascorbic acid is mediated primarily via cofactor activity, not via oxidative stress.

In vivo anti-tumor activity of high-dose parenteral ascorbic acid is mediated primarily via cofactor activity, not via oxidative stress.

Journal: bioRxiv : the preprint server for biology

Published: June 06, 2025

Utility of circulating tumor DNA in management of diverse renal malignancies: Insights from a case series in adjuvant and recurrent/metastatic settings.

Utility of circulating tumor DNA in management of diverse renal malignancies: Insights from a case series in adjuvant and recurrent/metastatic settings.

Journal: Med (New York, N.Y.)

Published: June 06, 2025

Long-term follow-up of metastatic renal myoepithelial carcinoma: case report and literature review.

Long-term follow-up of metastatic renal myoepithelial carcinoma: case report and literature review.

Journal: The Canadian journal of urology

Published: January 10, 2025

Considerations in Meta-Analysis of Immunotherapy for Advanced Cancers Other Than Melanoma-Reply.

Considerations in Meta-Analysis of Immunotherapy for Advanced Cancers Other Than Melanoma-Reply.

Journal: JAMA oncology

Published: February 01, 2024

Derivative survival analyses: Analysis methods to derive survival outcomes for the remainder patient cohort without individual patient data.

Derivative survival analyses: Analysis methods to derive survival outcomes for the remainder patient cohort without individual patient data.

Journal: Cell reports. Medicine

Published: October 31, 2023

Nivolumab Plus Ipilimumab vs Nivolumab Alone in Advanced Cancers Other Than Melanoma: A Meta-Analysis.

Nivolumab Plus Ipilimumab vs Nivolumab Alone in Advanced Cancers Other Than Melanoma: A Meta-Analysis.

Journal: JAMA oncology

Published: August 31, 2023

Neurological applications of belzutifan in von Hippel-Lindau disease.

Neurological applications of belzutifan in von Hippel-Lindau disease.

Journal: Neuro-oncology

Published: October 10, 2022

Functional succinate dehydrogenase deficiency is a common adverse feature of clear cell renal cancer.

Functional succinate dehydrogenase deficiency is a common adverse feature of clear cell renal cancer.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: July 16, 2021

Aggressive myoepithelial carcinoma with EWSR1-POU5F1 fusion highly responsive to Ewing sarcoma combination chemotherapy.

Aggressive myoepithelial carcinoma with EWSR1-POU5F1 fusion highly responsive to Ewing sarcoma combination chemotherapy.

Journal: Cancer

Published: July 16, 2020

HIF1α is not a target of 14q deletion in clear cell renal cancer.

HIF1α is not a target of 14q deletion in clear cell renal cancer.

Journal: Scientific reports

Published: July 15, 2020

Showing 1-12 of 41

Last Updated: 09/26/2026